Skip to search formSkip to main contentSkip to account menu

NCO 700

Known as: NCO-700 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Piperazines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Effects of Protease Inhibitors on Postischemic Recovery of the Heart
It is well known that activation of proteases in the lysosomes and cytosol is one of the mechanisms of ischemic injury. It might… 
2000
2000
Tumor apoptosis induced by epoxide-containing piperazines, a new class of anti-cancer agents
Purpose: The overall purpose of this study was to determine the potential efficacy of epoxide-containing piperazines as a new… 
1998
1998
Oxidation of defined antigens allows protein unfolding and increases both proteolytic processing and exposes peptide epitopes which are recognized by specific T cells
The participation of oxidative mechanisms in major histocompatibility complex (MHC) class II‐restricted antigen presentation was… 
1998
1998
Inhibition of cathepsin B does not affect the intracellular activation of trypsinogen by cerulein hyperstimulation in isolated rat pancreatic acinar cells.
Activation of trypsinogen is thought to trigger the autodigestive process in acute pancreatitis. The lysosomal enzyme cathepsin B… 
Highly Cited
1997
Highly Cited
1997
Menadione induces both necrosis and apoptosis in rat pancreatic acinar AR4-2J cells.
1994
1994
A protease inhibitor, NCO-700, improves the contractile function in stunned canine myocardium.
To explore the role of calcium-dependent protease in the stunned myocardium, open-chest dogs underwent 15 min of left anterior… 
1991
1991
Effect of NCO-700, an inhibitor of protease, on lysosomal rupture in the ischemic myocardium.
The effect of NCO-700 (1), a protease inhibitor, on subcellular distribution of lysosomal enzymes was studied in the ischemic… 
1986
1986
ANTIARRHYTHMIC EFFECTS OF POSSIBLE ANTI-ISCHEMIC DRUGS
1985
1985
Effect of NCO-700, an inhibitor of protease, on myocardial pH decreased by coronary occlusion in dogs.
During myocardial ischemia in dogs effects of NCO-700, a protease inhibitor on myocardial pH, were investigated. Ischemia was… 
1982
1982
Reduction of experimentally produced acute myocardial infarction size by a new synthetic inhibitor, NCO-700, against calcium-activated neutral protease.
Calcium-activated neutral protease (CANP) might be involved in the irreversible degradation of myocardial proteins in the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)